VIVES Funds

VIVES is a seed capital fund initiated by UCLouvain which invests in companies developing disruptive innovations with a positive societal impact.

Yannick Vancoppenolle

Partner

5 past transactions

BiocSol

Seed Round in 2024
BiocSol focus on sustainable microbial-based crop protection.

ATB Therapeutics

Series A in 2024
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

Generare

Seed Round in 2024
Generare is a biotechnology company specializing in the discovery of novel drug leads derived from soil bacteria. It has created a comprehensive map of the biosynthetic landscape, utilizing experimental data to predict and access valuable new molecules with novel modes of action, thereby aiding pharmaceutical companies and research institutions in drug development.

Brightflow

Series A in 2024
Brightflow operates as a medical device startup.

VOCSens

Seed Round in 2021
VOCSens is a company focused on developing innovative environmental monitoring solutions, particularly through its flagship product, EnviCam®. This advanced environmental camera enables users to visualize chemical and biochemical molecules that are otherwise invisible to traditional monitoring methods. The company has also established a proprietary manufacturing process, CMOSEnvi™, which integrates nanotechnology with conventional CMOS technology, enabling the production of microelectronic gas sensors. These sensors detect raw electrical signals from their sensing elements, which are then processed through proprietary artificial intelligence algorithms to provide accurate concentration data. VOCSens's technology aims to support various industries, including agriculture, food, chemicals, wastewater, and pharmaceuticals, by delivering critical insights and aiding in the control of industrial emissions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.